SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001104659-20-001225
Filing Date
2020-01-06
Accepted
2020-01-06 06:29:46
Documents
4
Group Members
MEDUSA MERGER CORP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A a19-26580_3sctota.htm SC TO-T/A 72619
2 EX-99.(A)(5)(D) a19-26580_3ex99da5d.htm EX-99.(A)(5)(D) 27498
3 GRAPHIC g265803lai001.jpg GRAPHIC 4911
4 GRAPHIC g265803lai002.jpg GRAPHIC 2805
  Complete submission text file 0001104659-20-001225.txt   112630
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 973-290-6000
MEDICINES CO /DE (Subject) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-60201 | Film No.: 20507991
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations